Fièvres récurrentes auto-inflammatoires
Veille bibliographique : Fièvres récurrentes auto-inflammatoires
Les articles sont classés du plus ancien au plus récent, n’hésitez pas à utiliser la barre de recherche pour filtrer les résultats par date par exemple.
| Giancane G et al. Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever. Ann Rheum Dis. 2015 Apr;74(4):635-641 | Lire le résumé |
| Federici S et al. ; for the Paediatric Rheumatology International Trials Organisation (PRINTO) and Eurofever Project. Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers. Ann Rheum Dis. 2015 Jan 30 | Lire le résumé |
| Nakagawa K et al. Somatic NLRP3 mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes. Ann Rheum Dis. 2015 Mar;74(3):603-10. | Lire le résumé |
| Özçakar ZB et al. Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis. Clin Rheumatol. 2016 Feb;35(2):441-6. | Lire le résumé |
| Ter Haar NM et al. The phenotype and genotype of mevalonate kinase deficiency: A series of 114 cases from the Eurofever Registry. Arthritis Rheumatol Hoboken NJ. 23 mai 2016 | Lire le résumé |
| Akula MK et al. Control of the innate immune response by themevalonate pathway. Nat Immunol. août 2016;17(8):922‑9. | Lire le résumé |
| Dorfleutner A, Stehlik C. A dRAStic RHOAdblock of Pyrin inflammasome activation. Nat Immunol. 19 juill 2016;17(8):900‑2. | Lire le résumé |
| Stankovic Stojanovic K et al. Concordance between CRP and SAA in familial Mediterranean fever during attack-free period: A study of 218 patients. Clin Biochem 10 nov 2016 | Lire le résumé |
| Ben-Zvi I et al. Anakinra for colchicine resistant familial Mediterranean fever - A randomized, double blind, placebo-controlled trial. Arthritis Rheumatol. 2016 Nov 11 | Lire le résumé |
| Ben-Zvi I et al. Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol Hoboken NJ. 2017 Apr;69(4):854–62. | Lire le résumé |
| Papa R et al. A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry. Orphanet J Rare Dis. 2017 Oct 18;12(1):167 | Lire le résumé |
| Mader S, Jeganathan V, Arinuma Y et al. Understanding the antibody repertoire in Neuropsychiatric Systemic Lupus Erythematosus and Neuromyelitis Optica Spectrum Disorders: do they share common targets? Arthritis Rheumatol Hoboken NJ. 2017 Oct 26 | Lire le résumé |
| Carapito R, Carapito C, Morlon A, Paul N, Vaca Jacome AS, Alsaleh G, et al. Multi-OMICS analyses unveil STAT1 as a potential modifier gene in mevalonate kinase deficiency. Annals of the Rheumatic Diseases. 2018 Jul 20;annrheumdis-2018-213524 | Lire le résumé |
| Butbul Aviel Y, Harel L, Abu Rumi M, Brik R, Hezkelo N, Ohana O, et al. Familial Mediterranean Fever Is Commonly Diagnosed in Children in Israel with Periodic Fever Aphthous Stomatitis, Pharyngitis, and Adenitis Syndrome. The Journal of Pediatrics. 2019 Jan;204:270–4 | Lire le résumé |
| Deshayes S, Fellahi S, Bastard J-P, Launay J-M, Callebert J, Fraisse T, et al. Specific changes in faecal microbiota are associated with familial Mediterranean fever. Ann Rheum Dis. 3 août 2019;annrheumdis-2019-215258 | Lire le résumé |
| Van Gorp H, Huang L, Saavedra P, Vuylsteke M, Asaoka T, Prencipe G, et al. Blood-based test for diagnosis and functional subtyping of familial Mediterranean fever. Ann Rheum Dis. 20 avr 2020;annrheumdis-2019-216701. | Lire le résumé |
| Klein A, Minden K, Hospach A, Foeldvari I, Weller-Heinemann F, Trauzeddel R, et al. Treat-to-target study for improved outcome in polyarticular juvenile idiopathic arthritis. Ann Rheum Dis. 16 avr 2020;annrheumdis-2019-216843 | Lire le résumé |
| Babaoglu H, Armagan B, Bodakci E, Satis H, Atas N, Sari A, et al. Predictors of persistent inflammation in familial Mediterranean fever and association with damage. Rheumatology [Internet]. 10 août 2020 [cité 23 nov 2020] | Lire le résumé |
| Georgin-Lavialle S, Abe E, Larabi A, Savey L, Ducharme-Bénard S, Hentgen V, et al. Could we measure hair colchicine to assess colchicine observance in familial Mediterranean fever? Rheumatology. 21 déc 2020;keaa811. | Lire le résumé |
| Tirosh I, Yacobi Y, Vivante A, Barel O, Ben-Moshe Y, Erez Granat O, et al. Clinical significance of E148Q heterozygous variant in paediatric Familial Mediterranean Fever. Rheumatology [Internet]. 9 févr 2021 [cité 19 févr 2021] | Lire le résumé |
| Magnotti F, Malsot T, Georgin-lavialle S, Abbas F, Martin A, Belot A, et al. Fast diagnostic test for familial Mediterranean fever based on a kinase inhibitor. Ann Rheum Dis. janv 2021;80(1):128‑32. | Lire le résumé |
| Levinsky Y, Azani L, Shkalim Zemer V, Chodick G, Tal R, Harel L, Amarilyo G. Adherence to colchicine prophylaxis among patients with familial Mediterranean fever treated with interleukin-1 inhibitors. Semin Arthritis Rheum. 2023 May 4;61:152211. doi: 10.1016/j.semarthrit.2023.152211. Epub ahead of print. PMID: 37201215. | Lire le résumé |
| Sener S, Cam V, Batu ED, Kasap Cuceoglu M, Balik Z, Aliyev E, Bayindir Y, Basaran O, Bilginer Y, Ozen S. Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever. Rheumatology (Oxford). 2023 Mar 24:kead128. doi: 10.1093/rheumatology/kead128. Epub ahead of print. PMID: 36961326. | Lire le résumé |
| Bitik B, Hatipoğlu B, Sayın B, Kanbur AY, Bursa N, Oygur CŞ, et al. Long-term results of kidney transplantation in patients with familial mediterranean fever. Clin Transplant. févr 2023;37(2):e14888. | Lire le résumé |
| Patt YS, Ben-Shabat N, Fisher L, Sharif K, Arow M, Lassman S, et al. Increased risk of osteoporosis and femoral neck fractures in patients with familial Mediterranean fever—a large retrospective cohort study. Rheumatology. 28 sept 2023;kead526 | Lire le résumé |
| Baspinar SN, Kilic B, Azman FN, Guler Y, Gunay UB, Tanin MK, et al. Cancer incidence in Familial Mediterranean Fever: A retrospective analysis. Semin Arthritis Rheum. déc 2023;63:152284. Brenner R, Ben‐Zvi I, Shinar Y, Liphshitz I, Silverman B, Peled N, et al. Familial Mediterranean Fever and Incidence of Cancer: An Analysis of 8,534 Israeli Patients With 258,803 Person‐Years. Arthritis Rheumatol. janv 2018;70(1):127‑33. Bilgin E, Dizdar Ö, Güven DC, Ceylan S, Aybi Ö, Fırlatan B, et al. Cancer incidence in familial Mediterranean fever patients: a retrospective analysis from central Anatolia. Rheumatol Int. juin 2019;39(6):1045‑51. | Lire le résumé |
| Ait-Idir D, Djerdjouri B, Latreche K, Sari-Hamidou R, Khellaf G. Predicting genetic risk factors for AA amyloidosis in Algerian patients with familial Mediterranean fever. Mol Genet Genomics. déc 2024;299(1):25 | Lire le résumé |
| 1. Öztürk K, Coşkuner T, Baglan E, Sönmez HE, Yener GO, Çakmak F, et al. Real-Life Data From the Largest Pediatric Familial Mediterranean Fever Cohort. Front Pediatr. 2021;9:805919 2. Giancane GTer Haar NM, Wulffraat N, Vastert SJ, Barron K, Hentgen V, et al. Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever. Ann Rheum Dis. avr 2015;74(4):635‑41 3. Sönmez HE, Esmeray P, Batu ED, Arıcı ZS, Demir S, Sağ E, et al. Is age associated with disease severity and compliance to treatment in children with familial Mediterranean fever? Rheumatol Int. janv 2019;39(1):83‑7 4. Tanatar A, Karadağ ŞG, Çakan M, Sönmez HE, Ayaz NA. Age of onset as an influencing factor for disease severity in children with familial Mediterranean fever. Mod Rheumatol. janv 2021;31(1):219‑22 5. Yalcinkaya F, Ozcakar ZB, Tanyildiz M, Elhan AH. Familial Mediterranean fever in small children in Turkey. Clin Exp Rheumatol. 2011;29(4 Suppl 67):S87-90 6. Gezgin Yıldırım D, Esmeray Senol P, Söylemezoğlu O. Predictors of persistent inflammation in children with familial Mediterranean fever. Mod Rheumatol. 1 juill 2022;32(4):803‑7 7. Erden A, Batu ED, Armagan B, Sönmez HE, Sarı A, Demir S, et al. Blood group « A » may have a possible modifier effect on familial Mediterranean fever and blood group « 0 » may be associated with colchicine resistance. Biomark Med. juin 2018;12(6):565‑72 8. Omma A Armaǧan B, Güven SC, Sandıkçı SC, Çolak S, Yücel Ç, et al. Endocan: A Novel Marker for Colchicine Resistance in Familial Mediterranean Fever Patients? Front Pediatr. 2021;9:788864 9. Erdem Gürsoy D, Gezer HH, Öz N, Özer A, Acer Kasman S, Duruöz MT. Colchicine resistance: Associated factors and its effect on health-related quality of life in patients with familial Mediterranean fever. Int J Rheum Dis. nov 2022;25(11):1239‑45 10. Mosad Mosa D, Shokry D, Ahmed DB, Sobh A. Early predictors of colchicine resistance in familial Mediterranean fever. Mod Rheumatol. 4 juill 2023;33(4):830‑5 11. Sahin N, Ozdemir Cicek S, Pac Kisaarslan A, Poyrazoglu MH, Gunduz Z, Dusunsel R. The remarkable characteristics of the children with colchicine-resistant familial Mediterranean fever in Turkey. Mod Rheumatol. 5 janv 2022;32(1):177‑85 12.Batu ED, Şener S, Arslanoglu Aydin E, Aliyev E, Bagrul İ, Türkmen Ş, et al. A score for predicting colchicine resistance at the time of diagnosis in familial Mediterranean fever: data from the TURPAID registry. Rheumatol Oxf Engl. 1 mars 2024;63(3):791‑7 | Lire le résumé |